Abstract. MicroRNAs have emerged as promising molecular factors with potential for clinical applications in cancer diagnosis and therapy. In the present study, we demonstrated that the level of miR-200c in lung cancer tissues was lower than that in normal tissues using real-time PCR. To further investigate the effects of miR-200c expression in lung cancer cells, we upregulated miR-200c levels in H460 cells using transfection. We found that the percentage of apoptotic cells was higher in the cells expressing miR-200c than that in the untransfected cells. 
Introduction
MicroRNAs (miRs) are evolutionary conserved small RNAs that modulate gene expression by inhibiting the protein translation process and/or degrading the respective target messenger RNA (1) . In the past few years, microRNAs have emerged as promising molecular factors with potential for clinical applications in cancer diagnosis and therapy (2, 3) . The miR-200 family of miRNAs consists of for five members (miR-200a, miR-200b, miR-200c, miR-141 and miR-429) expressed in two genomic clusters, one on chromosome 1p36.33 and the other on chromosome 12p12.31 (4) . Recent evidence shows that miRNA-200 family members play a central role in the process of epithelial-mesenchymal transition (EMT) (5, 6) . miR-200c has been shown to promote the upregulation of E-cadherin by directly targeting the transcription factor ZEB1 (7) . The importance of EMT in driving carcinogenesis has been shown in lung, breast, prostate, pancreatic and liver cancer (8, 9) .
Resveratrol (RESV) (trans-3,4,5-trihydroxystilbene), a natural polyphenolic extracted from red wine, has the potential to inhibit the growth of several types of cancers such as prostate, lung and colorectal cancers (10) (11) (12) . The role of miR-200c and RESV has been demonstrated in lung cancer, respectively; however, the synergistic antitumor activity of RESV and miR-200c remains unclear.
The aim of the present study was to identify potential roles and mechanisms of RESV and miR-200c in non-small cell lung cancer (NSCLC). Therefore, we specifically investigated i) the expression of miR-200c in the NSCLC cell line, H460, and its role in the proliferation of H460 cells; ii) the possible associations between miR-200c levels and RESV; and iii) the possible mechanisms involved in the enhancement of the antitumor activities of RESV by miR-200c.
Materials and methods
Subjects. Forty-two patients who were diagnosed with primary NSCLC at the Department of Thoracic Surgery, The First Affiliated Hospital of China Medical University from January 2006 to December 2010 were included in the present study. All diagnoses were based on standard laboratory tests (cytology and histology) and confirmed by computerized tomography of the thorax. None of the patients underwent radiotherapy or chemotherapy before the operation. The study was approved by the China Medical University Ethics Committee and was conducted by the Helsinki Declaration. All patients provided written informed consent to participate in the study.
H460 cell culture and transfection. The human non-small cell lung cancer cell line NCI-H460 was purchased from the American Type Culture Collection (ATCC; Manassas, VA, USA) and grown in RPMI-1640 culture medium containing 10% fetal bovine serum (FBS), 100 units/ml of penicillin, and 100 µg/ml streptomycin in humidified air (5% CO 2 atmosphere) at 37˚C. Cells were transfected with hsa-miR-200c (UAAUACUGCCGGGUAAUGAUGGA) (Open Biosystems, Huntsville, AL, USA) with RNAiFect transfection reagent (Qiagen, Gaithersburg, MD, USA). Resveratrol treatment and MTT assay. The transfected and untransfected cells were treated with RESV (Sigma Chemicals, St. Louis, MO, USA). MTT (10 µl, at 5 mg/ml) was added at a final concentration of 500 µg/ml, and the mixture was further incubated for 1 h at 37˚C, and the liquid in the wells was removed thereafter. DMSO (100 µl) was then added to each well, and the absorbance was read with a UVmax microplate reader (Molecular Devices, Sunnyvale, CA, USA) at 560 nm.
Synergistic antitumor activity of resveratrol and miR-200c in human lung cancer
Cell apoptosis assay. Cells (5x10 5 ) were collected without EDTA and washed with PBS. A 500 µl binding buffer, 5 µl Annexin V-FITC and 5 µl propidium iodide (PI) were added into the suspension in that order and mixed at room temperature in the dark for 10 min. The examination of apoptosis was performed by flow cytometry within 1 h.
Cell cycle assay. Cells seeded on 6-well plates were treated and then collected. After being washed with PBS three times, the cell suspension was fixed with 70% ethanol, and incubated with RNAse A at 37˚C. After being stained with 400 µl PI, the suspension was evaluated by flow cytometry.
Xenograft assays. All experiments using animals were performed according to the guidelines of the China Medical University Ethics Committee. Nude mice (nu/nu), 6-8 weeks of age, were purchased from Vital River Laboratories Co., Ltd. (Beijing, China). The animal facility was maintained under conditions of 20±2˚C, 50±10% humidity, and a 12-h light/dark cycle. H460 cells (3x10 7 in 200 µl) were subcutaneously injected into the axilla of each mouse. After the tumor diameters reached 3-5 mm, the mice were divided randomly into three groups and received a 200 µl intratumoral injection of miR-200c, RESV or both miR-200c and RESV. Two injections were administered at 10 a.m and 5 p.m. every two days. The tumor growth was then monitored for 30 days. Every five days until the end of the experiment, one mouse from each group was randomly selected to be sacrificed by CO 2 asphyxiation, and tumors were harvested and weighed. The tissue was fixed in 4% paraformaldehyde for histopathologic analysis. Additional mice (n=60) were used to establish xenografts to obtain survival curves. Mice with xenografted tumors (as described above) that reached 3-5 mm in diameter were divided into four groups (n=15 for each). Survival was monitored until the experiments were terminated due to the heavy tumor burden.
miRNA target prediction. The miRNA targets predicted by TargetScan (http://www.targetscan.org/) are based on the presence of conserved 8mer, 7mer and 6mer sites that match the seed region of each miRNA (13) . TargetScan also predicts non-conserved sites, additional types of seed matches that are preferentially conserved in different species, and sites with mismatches in the seed region that are compensated by conserved 3' pairing (14) .
Western blot analysis. Tissues and cells were lysed in lysis buffer (20 mM Tris-HCl, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100) containing a protease inhibitor cocktail (Sigma). Protein amounts were quantified using the BCA protein assay kit. Equivalent amounts of protein (20 µg) were separated using 12% SDS-PAGE and transferred to a PVDF membrane (Millipore Corporation, Billerica, MA, USA). Western blot analysis was performed using primary antibodies: RECK (Santa Cruz Biotechnology, Santa Cruz, CA, USA), stress-activated protein kinase/JNK antibody (Cell Signaling Technology, Beverly, MA, USA), phospho-stress activated protein kinase/p-JNK (Thr Statistical analysis. Data were analyzed using GraphPad Prism 5 software. Statistical analysis was performed using a one-tailed Student's t-test (unilateral and unpaired). KaplanMeier survival plots were generated, and comparisons between survival curves were carried out using the log-rank statistical analysis. P-values <0.05 were considered to indicate statistically significant differences. tissues was lower than that in the normal tissues as determined by real-time PCR (P<0.05; Fig. 1A) . To investigate the association of miR-200c with patient survival, the survival data from 42 patients with NSCLC were assessed. Kaplan-Meier analysis showed that miR-200c expression was closely correlated with the favorable prognosis of patients with NSCLC (P<0.05; Fig. 1B) .
Growth inhibitory effects of RESV in miR-200c-expressing H460 cells.
A slower growth rate of the miR-200c-expressing H460 cells was noted when compared with the untreated cells by using MTT assay (P<0.05; Fig. 2A ). Annexin V/ PI double staining showed a higher level of apoptosis in the miR-200c-expressing H460 cells (P<0.05; Fig. 2B ). PI staining of cells revealed that miR-200c-expressing H460 cells were arrested in the G 1 phase (Fig. 2C) . RESV also inhibited proliferation, induced apoptosis and G 1 arrest in H460 cells (Fig. 2) . Notably, RESV showed stronger antitumor activity in the miR200c-positive H460 cells than that in the negative miR-200c H460 cells. Furthermore, we confirmed that the activity of RESV in the miR-200c-positive H460 cells was not a simple summation of RESV and miR-200c (Fig. 2) .
RESV and miR-200c inhibit tumor growth and prolong the survival rate of mice in vivo.
We next determined whether RESV and miR-200c display antitumor activities in established xenograft tumor models. As shown in Fig. 3A , the tumor volumes of the RESV-treated and the miR-200c-treated mice were less than that of the untreated mice (P<0.05). Similarly, tumor weights for the RESV-treated group and the miR-200c-treated group were also significantly reduced when compared to that of the untreated group (P<0.05; Fig. 3B ). We also found that the RESV-treated and miR-200c-treated mice displayed a prolonged survival rate when compared to the untreated mice (P<0.05; Fig. 3C ). The results of the in vitro studies demonstrated that the combined treatment with RESV and miR-200c had the strongest antitumor activity in the established xenograft tumor models. No significant changes in JNK and c-jun were detected in the transfected cells. However, phosphorylated JNK and c-jun were increased. We then confirmed that caspase-3 and caspase-9 were activated in the transfected cells (Fig. 5) . RESV further enhanced RECK, BiP, CHOP, JNK, c-jun, caspase-3 and caspase-9 expression in the miR-200c-transfected cells but not in the untransfected cells (Fig. 5) .
Discussion
In the present study, we showed a highly significant correlation between relative miR-200c expression and the survival rate of the patients with NSCLC, indicating that its expression may be used as a valuable marker of lung cancer prognosis. Tang et al (15) also found that miR-200c was downregulated in gastric cancer specimens. Ceppi et al (16) confirmed that loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in nonsmall cell lung cancer. Consistent with their studies, we found that miR-200c could induce apoptosis and G 1 arrest in H460 cells. Furthermore, we found that RESV exhibited The main aim of the present study was to determine the potential mechanism of RESV in miR-positive H460 cells. Firstly, we identified the regulation of miR-200c by potential molecular targets by using TargetScan, such as ZEB1 and ZEB2. Then we focused on reversion-inducing cysteine-rich protein with Kazal motifs (RECK), a membrane bound protein.
Several studies have shown that RECK levels are significantly downregulated in human pancreatic, mammary, lung, prostate and colorectal cancers, as well as in hepatocarcinoma and neuroblastoma, when compared with the levels in the normal surrounding tissues (17) (18) (19) (20) . We confirmed that upregulation of miR-200c in H460 cells could increase RECK expression. The inhibitory role of RECK expression in cancer cells has been demonstrated both in previous (21) and in the present study. In addition to RECK expression, ER stress was detected in H460 cells. Chen et al (22) also found that RECK regulated endoplasmic reticulum stress response and enhanced cisplatininduced cell death in neuroblastoma cells. The alteration of the ER molecular chaperone GRP78/BiP expression levels can inhibit tumor growth in vivo (23) . Another study also confirmed that ER stress-induced apoptosis is highly dependent on the upregulation of the UPR-inducible transcription factor CHOP (24) . Consistent with previous studies, we found that the levels of BiP and CHOP in miR-200c-positive H460 cells were higher than levels in the untreated cells. This is the first study to explore the role of miR-200c in controlling RECK expression in H460 cell lines. Our data showed that miR-200c expression sensitizes H460 cells to RESV, and this is likely due to RECK expression.
